Playback speed
10 seconds
SABCS 2021 Update on QoL Results From OlympiA Trial: Adjuvant Olaparib After (Neo)Adjuvant Chemo in Patients With Germline BRCA1/2 Mutations and High-Risk HER2- EBC
By
SABCS 2021 Conference Coverage on VuMedi
FEATURING
Patricia Ganz
By
SABCS 2021 Conference Coverage on VuMedi
FEATURING
Patricia Ganz
284 views
December 23, 2021
Login to view comments.
Click here to Login